Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti

Use of Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti: Utility in Bending the Learning Curve for Global Programs

The researchers traveled to University Hospital Mirebalais in Haiti and provided a one week long laparoscopic training and simulation course to the 7 OBGYN faculty there. The researchers used novel checklists to help the faculty to set up for laparoscopic cases and care for the equipment needed. The researchers then asked the physicians their opinion of the checklists.

Study Overview

• Status: Completed
• Conditions: Surgery; Gynecology
• Intervention / Treatment: Procedure: Surgical training

• Study Type: Observational
• Enrollment (Actual): 7

Contacts and Locations

Study Locations

• Haiti
  • Mirebalais, Haiti
    • University Hospital at Mirebalais

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 60 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

OBGYN attendings and residents practicing at University Hospital of Mirebalais

Description

Inclusion Criteria:

• OBGYN physician in Haiti

Exclusion Criteria:

• none

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Physicians in Haiti; 7 OBGYN physicians underwent a laparoscopic training and simulation course and then were proctored as they performed 3 in vivo cases using a check list to help the participants remember all the steps of laparoscopic set-up.	Procedure: Surgical training; This was a gyn laparoscopy training and simulation course

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of physicians that reported favoring the checklist greater than 3 on a likert scale of 1-5.	Likert scale 1-5. 5 indicates highest satisfaction with the checklist.	1 week

Collaborators and Investigators

• Sponsor: Vanderbilt University Medical Center
• Investigators: Principal Investigator: Lara Harvey, MD MPH, Vanderbilt University Medical Center

Study record dates

Study Major Dates

• Study Start (Actual): September 29, 2018
• Primary Completion (Actual): October 6, 2018
• Study Completion (Actual): October 6, 2018

Study Registration Dates

• First Submitted: August 14, 2019
• First Submitted That Met QC Criteria: August 15, 2019
• First Posted (Actual): August 16, 2019

Study Record Updates

• Last Update Posted (Actual): August 30, 2019
• Last Update Submitted That Met QC Criteria: August 28, 2019
• Last Verified: August 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: 181435

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No